Literature DB >> 14659901

A new epitope tag from hepatitis B virus preS1 for immunodetection, localization and affinity purification of recombinant proteins.

Mee Sook Oh1, Keun Soo Kim, Young Kug Jang, Cheol Young Maeng, Soon Hong Min, Myeong Hee Jang, Sun Ok Yoon, Jung Hee Kim, Hyo Jeong Hong.   

Abstract

Previously, a murine monoclonal antibody (mAb) KR127 (IgG2a/kappa) that binds specifically to the preS1 of hepatitis B virus (HBV) was generated and the fine epitope was mapped to amino acids (aa) 37-45 (NSNNPDWDF). In this current study, the epitope in combination with KR127 was tested for protein tagging. Initially, to evaluate the importance of each residue of the KR127 epitope in antibody binding, alanine substitution mutants of the epitope were constructed and characterized for KR127 binding by immunoblot analysis and competition ELISA. The results showed that substitution of Ser(38) by alanine (S38A) increased the affinity to KR127. The mutated epitope (NANNPDWDF), designated S1 tag, was fused to the amino (N)- or carboxyl (C)-terminus of three human recombinant proteins, soluble B lymphocyte stimulator (sBLyS), the N-terminal domain of thrombopoietin (nTPO), and a mitochondrial ribosomal protein (CGI-113) for expression in mammalian cells, while it was fused to the N- or C-terminus of two proteins, a single-chain antibody fragment (ScFv) and the carboxyl-terminal domain (PAc) of the protective antigen of Bacillus anthracis for expression in Escherichia coli. The immunodetection, immunoprecipitation, and affinity purification of the expressed S1-tagged proteins by KR127 were successfully demonstrated. In addition, a KR127 mutant (AP2) with higher affinity, K(d) (0.9 nM), for the S1 tag compared to that (20 nM) of KR127 was obtained by mutational analysis of the heavy chain CDR3 (HCDR3) of KR127. The AP2 antibody was 4-fold more sensitive in detecting the S1-tagged protein than KR127. The S1 tag-KR127 or AP2 combination could be universally used for monitoring protein expression, localizing proteins, and protein purification, as well as studying protein interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659901     DOI: 10.1016/j.jim.2003.08.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.

Authors:  Nam-Kyu Lim; Jung-Hwan Kim; Mee Sook Oh; Sangyoon Lee; Se-Yeon Kim; Keun-Soo Kim; Hyun-Jung Kang; Hyo Jeong Hong; Kyung-Soo Inn
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.

Authors:  Eung Suk Lee; Mun Sik Jeong; Rohit Singh; Juyeon Jung; Hyunho Yoon; Jeong Ki Min; Kyung Hyun Kim; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

3.  Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM.

Authors:  Seulki Cho; Insoo Park; Haejung Kim; Mun Sik Jeong; Mooney Lim; Eung Suk Lee; Jin Hong Kim; Semi Kim; Hyo Jeong Hong
Journal:  MAbs       Date:  2016-01-19       Impact factor: 5.857

4.  Generation, Diversity Determination, and Application to Antibody Selection of a Human Naïve Fab Library.

Authors:  Sangkyu Kim; Insoo Park; Seung Gu Park; Seulki Cho; Jin Hong Kim; Nagesh S Ipper; Sun Shim Choi; Eung Suk Lee; Hyo Jeong Hong
Journal:  Mol Cells       Date:  2017-09-20       Impact factor: 5.034

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.